期刊名称 Diabetes Technology & Therapeutics
期刊缩写 DIABETES TECHNOL THE
学科分类 医学、生命科学
出版周期 双月刊
审稿速度 不详
投稿命中率 不详
期刊主页 http://online.liebertpub.com/dia
ISSN 号 1520-9156
IF 趋势 2005 2006 2007 2008 2009 2010 2011 2012
0 0 0 2.127 2.62 2.146 1.931 2.205
被收录情况 1. Science Citation Index Expanded
2. Current Contents - Clinical Medicine
PubSci评语 主要关注糖尿病及代谢综合症领域。国内投稿的人很少。无版面费和彩图费。论文有字数及图表限制。
期刊简介 该刊主要包括如下研究领域：长期微血管和大血管并发症的检测和预防、突破性技术以及新的治疗药物种类、糖尿病护理的行为方式及方法、最新进展以及新技术的应用，包括糖尿病给药的其他方法、持续血糖监测、人工胰脏、电脑化的案件管理和远程医疗、超快速起效的信胰岛素、低血糖的检测和预防。
投稿注意事项 特别提醒：无版面费及彩页费。有字数限制，原创性论文5000字以内，每张图标或图算400字；综述或邀请的论文在6000字以内，并不得超过2-3个表格或图；简要报告在1500-2000字以内，加一个图和表格；邀请的社论在1500字以内，不得超过1个表格或图，30篇以上的参考文献。
一般注意事项：
Diabetes Technology & Therapeutics will accept original papers and reviews about the use of technology and products to treat, diagnose, and prevent diabetes. Manuscripts submitted to Diabetes Technology & Therapeutics must not contain material that has been reported elsewhere (except in the form of an abstract published for a scientific meeting) or be under consideration for publication elsewhere. Prior abstracts should be described in a footnote to the title.
Diabetes Technology & Therapeutics is a rapid publication journal. Articles are published online ahead of print in 3-4 weeks.
PLEASE READ ALL THE INSTRUCTIONS TO AUTHORS BEFORE SUBMITTING.
All manuscripts must be submitted online athttp://mc.manuscriptcentral.com/diabetestechnology
PREPARATION OF MANUSCRIPT
Prepare manuscripts double-spaced. Leave ample margins on both sides, top and bottom.
Word limits are as follows:
Original paper: 5000 words, each table or figure accounts for 400 words.
Invited paper or review articles: 6000 words with no more than 2-3 tables or figures.
Brief reports: 1500-2000 words, plus 1 table and 1 figure.
Invited editorials: 1,500 words, with no more than 1 table or figure, and up to 30 references.
A title page should be part of your main text file and should include all authors’ names and affiliations, the funding source (if appropriate), and a running title of up to 45 characters. Please indicate the name, address, phone number, fax number, and e-mail address of the author to whom reprint requests should be addressed.
Include a minimum of five keywords on the title page to facilitate the review process.
The abstract should be no more than 250 words. Abstracts of original papers should contain four paragraphs labeled as: Background, Methods, Results, and Conclusions. Abstracts of reviews should contain a single unlabeled paragraph.
Disclosure Statement
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.”
In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.
Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journalsat http://www.icmje.org/index.html#conflicts for further guidance.
If no conflicts exist, the authors must state “No competing financial interests exist.
TABLES AND ILLUSTRATIONS
Tables should be prepared in Word and be supplied in a separate file from the text. Use Arabic numerals to number tables. Each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Details of experimental conditions should be included in the table footnotes. Information that appears in the text should not be repeated in the table, and tables should not contain data that can be given in the text in one or two sentences. Each supplied table must have a title.
Please submit artwork according to the following guidelines:
Please follow these guidelines for submitting artwork:
• Do NOT embed art files into a Word or PDF document.
• Line illustrations should be submitted at 900 dpi.
• Halftones and color should be submitted at a minimum of 300 dpi.
• Save as either TIFF or EPS files.
• Color art must be saved as CYMK - not RGB.
• Black and White art must be submitted as grayscale – not RGB.
• Do NOT submit PowerPoint, PDF, Bitmap or Excel files.
Please name your artwork files with the submitting authors name i.e. SmithFig1.tif, SmithTable2.tif etc. Authors who do not follow these guidelines may have their submission returned to them without being reviewed.
ADDITIONAL INFORMATION ABOUT ART FILES
Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
• All files should be scanned at 100% size.
• 300 dpi
• Final color mode: cmyk
• save file as: .tif or .eps
If you need directions on how to convert a Power Point slide to acceptable format go tohttp://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf
AUTHOR DISCLOSURE
All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.
REFERENCES
List references in consecutive numerical order (not alphabetically). All subsequent reference citations should be to the original number. Cite all references in the text or tables. Unpublished data and personal communications should not be listed as references. Abbreviations of journal titles should follow MEDLINE.
References to journal papers should include: (1) author(s) (list the first three authors, followed by et al. if applicable), (2) title, (3) journal name (as abbreviated in MEDLINE), (4) year, (5) volume number, and 6) inclusive page numbers, in that order.
References to books should include: (1) author(s), (2) chapter title (if any), (3) editor (if any), (4) title of book, (5) city of publication, (6) publisher, and (7) year. Volume and edition numbers, specific pages, and name of translator should be included when appropriate. The author is responsible for the accuracy and completeness of the references and for their correct text citation.
AUTHORSHIP
It is the submitting author’s responsibility to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship while the paper is in production – including page proofs – are NOT permitted. Changes in authorship after publication are strictly prohibited.
PATIENT RELEASE INFORMATION
If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients. The submitting author should provide written confirmation of this critical information. Acceptable forms of consent statements are emails or letters. The Journal does not provide a generic patient release form.
The written consent must contain specific information about the patient's name, age, and if pertinent, conservatorship -- as well as stated permission -- granting the Journal the rights to publish the photograph within its pages (which includes the name of the Journal and article title).
PERMISSIONS
The author must obtain permission to reproduce figures, tables and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure or legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material and should accompany the manuscript.
REPRINTS
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
PUBLISHER
The Journal is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: 914-740-2100; fax: 914-740-2101. E-mail: info@liebertpub.com Online:www.liebertpub.com
编辑部信息 所在地： 奥罗拉 国家 美国
Editor-in-Chief
Satish K. Garg, MD
University of Colorado Denver
Barbara Davis Center for Childhood Diabetes
1775 Aurora Court, A140
Aurora, CO 80045
Telephone: (303) 724-6713, (303) 724-6770
Fax: (303) 724-6784 or 6797
Satish.garg@ucdenver.edu
Senior Editors
Jay S. Skyler, MD, MACP
University of Miami Miller School of Medicine
Miami, FL
Irl B. Hirsch, MD
University of Washington Medical Center–Roosevelt
Seattle, WA
Associate Editor
Stuart A. Weinzimer, MD
Yale University School of Medicine
New Haven, CT
stuart.weinzimer@yale.edu
International Associate Editors
Peter Colman, MD
The Royal Melbourne Hospital
Parkville, Victoria, Australia
J. Hans DeVries, MD, PhD
University of Amsterdam
Amsterdam, The Netherlands
Linong Ji, MD
Peking University Diabetes Center
Peking, P.R. China
V. Mohan, MD
Dr. Mohan’s Diabetes Specialties Centre
Madras Diabetes Research Foundation
Chennai, India
Naoko Tajima, MD
Jikei University School of Medicine
Tokyo, Japan
Editorial Coordinator
Dawn White
Adult Clinic Administrative Assistant
University of Colorado Denver
Barbara Davis Center for Childhood Diabetes
1775 Aurora Court
Aurora, CO 80045
Telephone: (303) 724-6770
Fax: (303) 724-6784
Dawn.white@ucdenver.edu
网友投稿经验整理：无
